MedPath

LABETALOL HYDROCHLORIDE INJECTION IN 0.72% SODIUM CHLORIDE

LABETALOL HYDROCHLORIDE INJECTION IN 0.72% SODIUM CHLORIDE

Approved
DIN Number

02557037

Drug Class

Human

Market Date

N/A

Company
HC

hikma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02557037
AIG Number0116170004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AG01 LABETALOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LABETALOL HYDROCHLORIDEActive
Strength: 1 MG / ML
Monograph: LABETALOL HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.